2015
DOI: 10.1186/s12872-015-0086-1
|View full text |Cite
|
Sign up to set email alerts
|

Yoga’s effect on inflammatory biomarkers and metabolic risk factors in a high risk population – a controlled trial in primary care

Abstract: BackgroundYoga can reduce blood pressure and has also been suggested to reduce inflammatory biomarkers and metabolic risk factors for cardiovascular diseases (CVDs). We aimed to assess the benefit of two yoga interventions on inflammatory biomarkers and metabolic risk factors in a high risk population in primary care.MethodsAdult patients from a health care center in Sweden, with diagnosed hypertension, were invited to undergo a baseline check at the health care center. Baseline check included standardized blo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(21 citation statements)
references
References 19 publications
0
20
0
1
Order By: Relevance
“…The review included three studies with quasi-experimental designs (Cho, Moon, & Kim, 2015; Parma et al, 2015; Wolff et al, 2015) and two single-group pre–post studies (Sarvottam, Magan, Yadav, Mehta, & Mahapatra, 2013; Yadav, Magan, Mehta, Sharma, & Mahapatra, 2012), with the remaining 10 studies being randomized controlled trials. A total of five studies had waitlist control groups (Harkess, Ryan, Delfabbro, & Cohen-Woods, 2016; Kiecolt-Glaser et al, 2014; Rajbhoj, Shete, Verma, & Bhogal, 2015; Shete, Verma, Kulkarni, & Bhogal, 2017; Singh, Bhandari, & Rana, 2011) and four used usual-care or no-treatment groups (Cho et al, 2015; Pullen et al, 2008; Pullen et al, 2010; Wolff et al, 2015). Neither the waitlist control nor the usual-care groups were matched in general structure to the treatment groups in any of the relevant studies, which can threaten internal validity and impact the study outcomes (Mohr et al, 2009).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…The review included three studies with quasi-experimental designs (Cho, Moon, & Kim, 2015; Parma et al, 2015; Wolff et al, 2015) and two single-group pre–post studies (Sarvottam, Magan, Yadav, Mehta, & Mahapatra, 2013; Yadav, Magan, Mehta, Sharma, & Mahapatra, 2012), with the remaining 10 studies being randomized controlled trials. A total of five studies had waitlist control groups (Harkess, Ryan, Delfabbro, & Cohen-Woods, 2016; Kiecolt-Glaser et al, 2014; Rajbhoj, Shete, Verma, & Bhogal, 2015; Shete, Verma, Kulkarni, & Bhogal, 2017; Singh, Bhandari, & Rana, 2011) and four used usual-care or no-treatment groups (Cho et al, 2015; Pullen et al, 2008; Pullen et al, 2010; Wolff et al, 2015). Neither the waitlist control nor the usual-care groups were matched in general structure to the treatment groups in any of the relevant studies, which can threaten internal validity and impact the study outcomes (Mohr et al, 2009).…”
Section: Resultsmentioning
confidence: 99%
“…Two studies provided education as a control condition (Bower et al, 2014; Rao et al, 2017), and one used equal time and attention (Sohl et al, 2016). Finally, two of the studies used three-arm intervention trials comparing yoga against two control groups (Parma et al, 2015; Wolff et al, 2015).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…A svéd Kundalini-jógát használták 28 metabolikus szindrómás, hypertoniás, gyógyszert szedő betegen heti 60 perc felügyelt és otthoni minden nap 30 perces jógagyakorlással a "szokásos kezeléssel" szemben. Bár a szerzők korábbi tanulmányában a Kundalini-jóga vérnyomáscsökkenést váltott ki, ebben a vizsgálatban változott a vérnyomás és a vérparaméterek változatlanok maradtak, amit a szerzők a maximális vérnyomáscsökkentő gyógyszereléssel magyaráztak [31].…”
Section: Jóga Mint Preventív Eljárás a Kardiometabolikus Megbetegedésunclassified